top of page

Biosynthesis of Cannflavins A and B from Specialized Botanical Systems

Updated: Aug 6

Biosynthesis of Cannflavins A and B | Canurta Therapeutics

This paper discusses the biosynthesis of two specialized metabolites, cannflavin A and B, which exhibit potent anti-inflammatory activity. It identifies an aromatic prenyltransferase (CsPT3) that catalyzes the regiospecific addition of either geranyl diphosphate (GPP) or dimethylallyl diphosphate (DMAPP) to the methylated flavone chrysoeriol, producing cannflavins A and B, respectively. Additionally, an O-methyltransferase (CsOMT21) was identified that converts the plant flavone luteolin to chrysoeriol. These findings offer a promising avenue for metabolic engineering strategies aimed at producing these medicinally relevant compounds.


Learn more about this paper and its findings here: https://www.sciencedirect.com/science/article/pii/S0031942218303819

Canurta Therapeutics Logo

Transforming Rare Polyphenols into Botanical Drugs

  • Youtube
  • X
  • LinkedIn

Stay connected & receive updates on new discoveries, product innovation and more.

Thank you for subscribing.

© 2025 Canurta, Inc. All rights reserved.

bottom of page